Recall of ANTI-CD30 (BER-H2) MOUSE MONOCLONAL PRIMARY ANTIBODY

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ROCHE DIAGNOSTICS.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    20116
  • Event Risk Class
    III
  • Event Initiated Date
    2015-07-21
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    A slight decrease of the staining intensity and percent positive cells was observed. no cases demonstrating complete negative (false negative results) were observed. the investigation results support that the expiration date for the affected lot numbers should be set to 18 months from the date of manufacture instead of the currently marked 24 months.

Device

  • Model / Serial
    Model Catalog: 790-4858 (Lot serial: E03668); Model Catalog: 790-4858 (Lot serial: E05896); Model Catalog: 790-4858 (Lot serial: D09123); Model Catalog: 790-4858 (Lot serial: E00209)
  • Product Description
    ANTI-CD30 (BER-H2) MOUSE MONOCLONAL PRIMARY ANTIB
  • Manufacturer

Manufacturer

  • Manufacturer Address
    LAVAL
  • Manufacturer Parent Company (2017)
  • Source
    HC